The Research Center Borstel – Leibniz Lung Center is a German interdisciplinary biomedical research institution located in Borstel in Schleswig-Holstein, just north of Hamburg. It is affiliated with the Leibniz Association. It was founded in 1947 as a research institute with the main focus on tuberculosis and leprosy.

During the past decade, Forschungszentrum Borstel conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Forschungszentrum Borstel" #1 collaborator was "CAPNETZ Stiftung" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Forschungszentrum Borstel" are "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Chronic Obstructive Pulmonary Disease (COPD)" (1 trials). Many other conditions were trialed in "Forschungszentrum Borstel" in a lesser frequency.

Most popular intervention types in "Forschungszentrum Borstel" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Cisplatin" (1 trials), "Erlotinib" (1 trials), "Gemcitabine" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Forschungszentrum Borstel" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Forschungszentrum Borstel". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Forschungszentrum Borstel, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Forschungszentrum Borstel, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".